Pharmerica (PMC) Tops Q4 EPS by 4c; Guides FY16 EPS Below Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
PharMerica Reports Fourth Quarter and Full Year 2015 Results
February 26, 2016 8:01 AM ESTSolid Sequential Improvement in Revenue, Gross Profit, Adjusted EBITDA and Adjusted Diluted Earnings Per Share
Announces Full Year 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a diversified national provider of institutional and specialty pharmacy services, today reported its financial results for the fourth quarter and full year ended December 31, 2015.
             4Q15 Results  ÂComparison to4Q14
 ÂComparison to3Q15
Revenue   $520.6 million   Decrease of 0.6%   Increase of 4.4%Adjusted EBITDA
... More


